These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9682830)

  • 1. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.
    Crawford F; Fallin D; Suo Z; Abdullah L; Gold M; Gauntlett A; Duara R; Mullan M
    Neurosci Lett; 1998 Jun; 249(2-3):115-8. PubMed ID: 9682830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
    Lehmann DJ; Johnston C; Smith AD
    Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
    Wiebusch H; Poirier J; Sévigny P; Schappert K
    Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.
    Hiltunen M; Mannermaa A; Helisalmi S; Koivisto A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
    Neurosci Lett; 1998 Jun; 250(1):69-71. PubMed ID: 9696068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
    Yamamoto Y; Yasuda M; Mori E; Maeda K
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
    McIlroy SP; Crawford VL; Dynan KB; McGleenon BM; Vahidassr MD; Lawson JT; Passmore AP
    J Med Genet; 2000 Mar; 37(3):182-5. PubMed ID: 10699053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
    Kehoe PG; Williams H; Holmans P; Wilcock G; Cairns NJ; Neal J; Owen MJ
    J Med Genet; 1998 Dec; 35(12):1034-5. PubMed ID: 9863603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
    Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
    Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.
    Singleton AB; Smith G; Gibson AM; Woodward R; Perry RH; Ince PG; Edwardson JA; Morris CM
    Hum Mol Genet; 1998 May; 7(5):937-9. PubMed ID: 9536100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B
    Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
    Nassar BA; Darvesh S; Bevin LD; Rockwood K; Kirkland SA; O'Neill BJ; Bata IR; Johnstone DE; Title LM
    Clin Biochem; 2002 May; 35(3):205-9. PubMed ID: 12074828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
    Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
    Brindle N; Song Y; Rogaeva E; Premkumar S; Levesque G; Yu G; Ikeda M; Nishimura M; Paterson A; Sorbi S; Duara R; Farrer L; St George-Hyslop P
    Hum Mol Genet; 1998 May; 7(5):933-5. PubMed ID: 9536099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase K variant and cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Stroke; 1998 Dec; 29(12):2488-90. PubMed ID: 9836756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
    Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
    Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.